These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21425269)

  • 21. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A
    Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
    De Stefano N; Narayanan S; Francis GS; Arnaoutelis R; Tartaglia MC; Antel JP; Matthews PM; Arnold DL
    Arch Neurol; 2001 Jan; 58(1):65-70. PubMed ID: 11176938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
    Rahmanzadeh R; Lu PJ; Barakovic M; Weigel M; Maggi P; Nguyen TD; Schiavi S; Daducci A; La Rosa F; Schaedelin S; Absinta M; Reich DS; Sati P; Wang Y; Bach Cuadra M; Radue EW; Kuhle J; Kappos L; Granziera C
    Brain; 2021 Jul; 144(6):1684-1696. PubMed ID: 33693571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis.
    Gass A; Rocca MA; Agosta F; Ciccarelli O; Chard D; Valsasina P; Brooks JC; Bischof A; Eisele P; Kappos L; Barkhof F; Filippi M;
    Lancet Neurol; 2015 Apr; 14(4):443-54. PubMed ID: 25748099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
    Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
    Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
    J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M; Agosta F
    Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Starting early: MRI evidence of gray matter atrophy in children with multiple sclerosis.
    Banwell BL; Sled JG
    Neurology; 2008 Mar; 70(13 Pt 2):1065-6. PubMed ID: 18362266
    [No Abstract]   [Full Text] [Related]  

  • 30. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
    Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI measures of neuroprotection and repair in multiple sclerosis.
    Inglese M
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S16-23. PubMed ID: 22206761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.
    Tallantyre EC; Bø L; Al-Rawashdeh O; Owens T; Polman CH; Lowe J; Evangelou N
    Brain; 2009 May; 132(Pt 5):1190-9. PubMed ID: 19420101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord.
    Zackowski KM; Smith SA; Reich DS; Gordon-Lipkin E; Chodkowski BA; Sambandan DR; Shteyman M; Bastian AJ; van Zijl PC; Calabresi PA
    Brain; 2009 May; 132(Pt 5):1200-9. PubMed ID: 19297508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
    Rovaris M; Judica E; Sastre-Garriga J; Rovira A; Sormani MP; Benedetti B; Korteweg T; De Stefano N; Khaleeli Z; Montalban X; Barkhof F; Miller DH; Polman C; Thompson AJ; Filippi M
    Mult Scler; 2008 May; 14(4):455-64. PubMed ID: 18208869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microstructural MR Imaging Techniques in Multiple Sclerosis.
    Filippi M; Preziosa P; Rocca MA
    Neuroimaging Clin N Am; 2017 May; 27(2):313-333. PubMed ID: 28391789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in imaging of multiple sclerosis.
    Poloni G; Minagar A; Haacke EM; Zivadinov R
    Neurologist; 2011 Jul; 17(4):185-204. PubMed ID: 21712664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
    Kearney H; Yiannakas MC; Samson RS; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    Brain; 2014 Sep; 137(Pt 9):2456-68. PubMed ID: 24966048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.
    Rocca MA; Sormani MP; Rovaris M; Caputo D; Ghezzi A; Montanari E; Bertolotto A; Laroni A; Bergamaschi R; Martinelli V; Comi G; Filippi M
    Brain; 2017 Nov; 140(11):2814-2819. PubMed ID: 29053836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
    Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
    JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.